Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.

Research output: Contribution to journalLetter

Details

Authors
Organisations
External organisations
  • AstraZeneca, Sweden
  • University of Gothenburg
  • University of Oxford
  • Karolinska Institutet
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Infectious Medicine
Original languageEnglish
JournalJournal of Acquired Immune Deficiency Syndromes
Volume71
Issue number3
Early online date2015 Oct 21
Publication statusPublished - 2016
Publication categoryResearch
Peer-reviewedYes

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Clinical Virology, Malmö (013017580), Faculty of Medicine (000022000), Department of Experimental Medical Science (013210000), Division of Medical Microbiology (013250400), Division of Infection Medicine (SUS) (013008000), Brain Repair and Imaging in Neural Systems (BRAINS) (013212027), Drug Target Discovery (013212045)